`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`FRESENIUS KABI USA LLC
`
`Petitioner,
`
`
`
`v.
`
`
`
`CUBIST PHARMACEUTICALS, INC.
`
`Patent Owner.
`
`
`
`Case: IPR2015-01571
`Patent No. 8,058,238
`
`
`
`
`JOINT REQUEST TO FILE AGREEMENT AS
`BUSINESS CONFIDENTIAL INFORMATION
`UNDER 35 U.S.C. § 317(b) AND 37 C.F.R. § 42.74
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74, Petitioner Fresenius
`
`Kabi USA LLC and Patent Owner Cubist Pharmaceuticals LLC jointly request to
`
`file the Stipulation and Agreement to Narrow Issues in The Litigation and IPR
`
`Proceedings and Covenant Not to Sue, as referenced in the Joint Motion to Limit
`
`Petition and filed herewith as Exhibit 1041, as business confidential information,
`
`which shall be kept separate from the files of the involved patents.
`
`
`Respectfully submitted,
`
`/Elizabeth J. Holland/
`Elizabeth J. Holland
`Reg. No. 47,657
`Lead Attorney for Petitioner Fresenius Kabi
`USA LLC
`
`
`
`Respectfully submitted,
`
`/Emily R. Whelan/
`Emily R. Whelan
`Reg. No. 50,391
`Lead Attorney for Patent Owner Cubist
`Pharmaceuticals LLC
`
`
`
`
`Dated: September 1, 2015
`
`
`
`
`
`
`Dated: September 1, 2015
`
`1
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that “Joint Request to File an Agreement as Business
`
`Confidential Information under 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74” was
`
`served via electronic mail on September 1, 2015, upon:
`
`Emily R. Whelan, Emily.Whelan@wilmerhale.com
`Andrej Barbic, Ph.D., Andrej.Barbic@wilmerhale.com
`Gerard M. Devlin, Jr., Gerard.Devlin@merck.com
`Lisa A. Jakob, Lisa.Jakob@merck.com
`
`/Ryan C. Curiel/
`Ryan C. Curiel
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, New York 10018-1405
`Tel: 212-813-8800
`Fax: 212-355-3333
`rcuriel@goodwinprocter.com
`
`
`
`2
`
`
`
`Dated: September 1, 2015